Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of add-on Lantus during temporary interruption of insulin pump therapy on time to ketosis development
2004-002329-32Phase 4Completed
- Sponsor
- Karolinska Institutet Danderyds Sjukhus
- Start
- Oct 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin glargine and human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Karolinska Institutet Danderyds Sjukhus. Primary endpoint: Primary evaluation variable(s). Started Oct 2004; status: completed.
02
Drugs
insulin glarginehuman insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2004-002329-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002329-32.